We worked with 52 North Health to design and develop the test housing of their NeutroCheck Lateral Flow test that helps assess a cancer patient’s risk of Neutropenic Sepsis
An example of how eg worked to provide regulatory compliance and demonstrate safe and effective use for an at-home, non-invasive diagnostic device to be used by the general public.
